Affiliation:
1. Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
2. Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
3. School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
Abstract
This study investigated short-term outcomes of robotic versus laparoscopic hysterectomy for endometrial cancer (EC) in women with diabetes. We extracted the data of hospitalized females aged ≥18 years who were diagnosed with EC and diabetes and underwent robotic or laparoscopic hysterectomy from the US Nationwide Inpatient Sample (NIS) 2005–2018. Associations between study variables and in-hospital outcomes, including complications, unfavorable discharge, length of stay (LOS), and hospital costs, were examined using logistic regression. A total of 5745 women (representing 28,176 women in the US) were included. Multivariable analysis revealed that robotic surgery was significantly associated with a decreased risk of unfavorable discharge (adjusted odds ratio [aOR] = 0.63, 95% confidence interval [CI]: 0.46, 0.85) than pure laparoscopic surgery. Women who underwent robotic surgery had a significantly shorter LOS (0.46 fewer days, 95% CI: −0.57, −0.35) but higher total hospital costs (6129.93 greater USD; 95% CI: 4448.74, 7811.12). Compared with pure laparoscopic surgery, robotic hysterectomy was associated with less unfavorable discharge among women aged ≥60 years (aOR = 0.60, 95% CI: 0.44, 0.80). For US women with EC and diabetes, robotic hysterectomy is associated with shorter LOS, decreased risk of unfavorable discharge, especially among older patients, and higher total costs than laparoscopic surgery.
Reference28 articles.
1. Differential trends in rising endometrial cancer incidence by age, race, and ethnicity;Liu;JNCI Cancer Spectr.,2023
2. Endometrial Cancer;Lu;N. Engl. J. Med.,2020
3. Global, Regional, and National Burden of Endometrial Cancer, 1990–2017: Results from the Global Burden of Disease Study, 2017;Zhang;Front. Oncol.,2019
4. Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?;Cosgrove;Oncologist,2021
5. Hysterectomy-current methods and alternatives for benign indications;Papadopoulos;Obstet. Gynecol. Int.,2010